Introduction
============

Human bladder cancer (BCa), one of the most common genitourinary malignancies arising from mucous membrane, accounts for \>3% of all malignant tumors around the world and more and more people are diagnosed each year ([@b1-mmr-16-06-8709]). Early stage of bladder cancers do not usually cause symptoms and, with regard to those of late stage, it still frequently recurs and gradually progresses into muscle invasive BCa ([@b2-mmr-16-06-8709]). The gold standard of BCa diagnosis is based on cystoscopy, which is invasive and relatively expensive. Currently, non-invasive and specific markers are used for urinary cytology, however, this method is not sensitive to detection of low-grade BCa. Thus, new, highly sensitive and specific urine-based diagnostic tools are particularly attractive because urine is a promising and readily available source for molecular markers, including RNA.

As small nucleotides of RNA, by binding to complementary sequences in the 3′-untranslated regions of specific mRNAs, micro (mi)RNAs inhibit the translation of specific target genes ([@b3-mmr-16-06-8709]). In previous years, many cardinal cellular and physiological processes have been demonstrated to be associated with altered change in miRNAs expression levels ([@b4-mmr-16-06-8709]--[@b6-mmr-16-06-8709]). miRNAs are involved in the regulation of various cellular processes including cellular differentiation, cell cycle progression and apoptosis. Moreover, miRNAs, as important factors in tumorigenesis and metastasis and their expression signatures are associated with the prognosis and progression in a variety of cancers ([@b7-mmr-16-06-8709]--[@b9-mmr-16-06-8709]). Therefore, the authors could suppose that those miRNAs of which the expressions are changed significantly in tumors relative to normal tissues may have influence on tumor progression ([@b10-mmr-16-06-8709]). Moreover, identifying target genes united with differentially expressed miRNAs might illustrate the roles of miRNAs in cancer biology ([@b11-mmr-16-06-8709]). Previous studies have reported that we could distinguish malignant or normal tissue, as well as various tumor entities by miRNA expression profiles ([@b12-mmr-16-06-8709]--[@b16-mmr-16-06-8709]). As highly stable molecules, the authors could quantify miRNAs in tissues and body fluids, which makes them considered as promising cancer biomarkers. It has been reported that diagnosis, stage and sub-classification of cancer can be explored by differentially expressed miRNAs, which also can predict treatment efficacy and prognosis ([@b4-mmr-16-06-8709]). However, the molecular mechanisms are not yet clearly elucidated, which makes it necessary to identify novel miRNAs.

In the present study, the group performed an MIBC-related miRNA expression profile, so as to address the functional roles of miRNAs in MIBC. Several human MIBC tissues and normal bladder tissues were conducted to conduct a microarray analysis (GEO accession No. GSE76211), revealing several differentially expressed miRNAs. The putative target genes of dysregulated miRNAs were predicted using miRNA databases. Then the networks among miRNAs and genes, gene ontologies (GOs) and pathways were built. The purpose of the current study was to identify candidate predictive tumor-associated miRNAs in MIBC patients.

Materials and methods
=====================

### Preparation for human bladder samples

Three MIBC tissues samples were collected from patients after surgery at Zhongnan Hospital of Wuhan University (Wuhan, China). Three normal bladder tissue samples were collected from donors by accidental death. Information of the MIBC patients and donors was listed in [Table I](#tI-mmr-16-06-8709){ref-type="table"}. Those samples used in the study have been described in previous publication ([@b17-mmr-16-06-8709]--[@b19-mmr-16-06-8709]). Briefly, two pathologists confirmed the histology diagnosis independently and all the tissues were snap-frozen for total RNA isolation at liquid nitrogen after excision from operation room. Informed consent was obtained for surgery patients and normal donors from the patients and their relatives, respectively. The Ethics Committee at Zhongnan Hospital of Wuhan University (Wuhan, China) approved the experiments using human bladder tissue samples for RNA isolation analysis (approval number: 2015029). All methods used for human bladder tissue samples were performed in accordance with the approved guidelines and regulations.

### RNA extraction

Based on the manufacturer\'s protocol, total RNA was extracted from the frozen tissue block using RNeasy Mini kit (cat. no. 74101, Qiagen GmbH, Hilden, Germany), combined with QIAshredder (cat. no. 79654, Qiagen GmbH) using a centrifuge (cat. no. 5424, Eppendorf, Hamburg, Germany). In order to remove genomic DNA, DNase I digestion (cat. no. 79253, Qiagen GmbH), DNase I digestion (cat. no. 79254, Qiagen GmbH) was used in each RNA preparation.

### miRNA microarray

After assessing RNA quality and quantity, the miRNAs microarray analysis (Affymetrix microRNA 4.0 Array, Affymetrix, Inc., Santa Clara, CA, USA) was performed according to the manufacturer\'s instructions. Briefly, 1 µg of total RNA was labeled with Biotin using the FlashTag Biotin HSR RNA Labeling kit (Genisphere LLC, Hatfield, PA, USA) and then hybridized overnight with the array, which was washed, stained, and read by an GeneChip Scanner 3000 7G (Affymetrix, Inc.). MiRNA microarray data GSE40355 used for validation were obtained from Gene Expression Omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo/>). This dataset included eight normal bladder tissues samples, eight low grade BCa tissues samples and eight high grade BCa tissue samples. Among them, significant expressed miRNAs were screened out from high grade BCa tissues compared with normal bladder tissues.

### Data analysis of miRNAs microarray

CEL-files of the raw data were first exported by Affymetrix GeneChip Command Console Software Version 4.0 (Affymetrix, Inc.) and then uploaded to the website of Gminix-Cloud Biotechnology Information (GCBI) by Genminix Informatics Co., Ltd. (Shanghai, China; <http://www.gcbi.com.cn/gclib/html/index>) for further analysis, including difference analysis of miRNAs profiles, prediction of miRNAs target genes, GO/pathway enrichment analysis, miRNAs-gene-network and miRNAs-GO-network analysis. The miRNAs array data used in the present paper has been uploaded to the NCBI Gene Expression Omnibus and the GEO accession number is GSE76211.

According to the GCBI online method description for difference analysis, the procedure for candidate miRNAs selection is as follows: When the number of samples in each group is no less than 3, SAM method is used for difference analysis. The authors implemented a series of steps to obtain the estimation of significance of difference and false discovery rate for every filtered gene:

i\) Calculate the exchange factor s~0~: Firstly, calculate the standard deviation for all genes, denote s^α^ as the α percentile for s~i~. For the percentile value q~1~ \< q~2~ ... q~100~ of the s~i~, calculate the statistic:
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Where mad denotes the mean absolute deviation. At last, α (denote as ᾶ) was selected to make the CV (coefficient of variation) of the v~j~ achieve minimum. Then, the exchange factor s~0~ is s^ᾶ^ used.

ii\) Calculate the statistic value (d Score) for every gene:
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Where r~i~ reflects the difference in average level among different groups, s~i~ reflects the variation of sample population. See details in references ([@b20-mmr-16-06-8709],[@b21-mmr-16-06-8709])

iii\) Calculate the order statistic:
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iv\) In order to get the above statistic\'s estimate, the authors made a permutation method (a loop strategy through every sample, the total number no less than 1,000; the detail are omitted) the expected distribution of d score. The estimated statistic values are denoted as follows:
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v\) The authors obtain the order statistic value under the permutation:
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vi\) By calculating the maximum distance between the order statistic d~(i)~ and the expected order statistic ${\overline{d}}_{(i)}$, the authors constructed a series of rejection regions for q-value. In fact, a grid of delta values was obtained by dividing 50 equivalent delta value for the above distance.

vii\) For a fixed delta value, by computing the difference ∆~(i)~ ~=~ d~(i)~ -${\overline{d}}_{(i)}$ the authors identified the nearest ∆~(i)~ for gene i. The cut-up is marked as min {∆~(i)~ ~≥\ delta~} for positive gene and the cut-down max {∆~(i)~ ~≤\ delta~} as for negative gene. The genes with differences above the cut-up value (we denote the number of these genes as R~(p)~) were considered as significantly positive genes. While the genes with differences lower than the cut-down value were considered as significantly negative genes.

viii\) Under the above cut-up and cut-down thresholds, the simulation of step VII was performed respectively on the statistics obtained from step V, such that the number of positive genes could be obtained under random state (≥1,000 permutations). The median of the 1,000 positive genes was estimated as the number of false positive genes, to allow the false discovery rate (FDR) to be estimated (the positive $\text{FDR} = \frac{V_{(p)}}{R_{(p)}}$ and the negative FDR was similar), and thus the proportion of false positive genes in the full set of positive genes.

ix\) Finally, according to the definition of q-value ([@b22-mmr-16-06-8709]), the authors obtained the q-value for the gene, i, by selecting the minimum of the FDR for the 50 delta values determined in step VII (every delta as a rejection region).

Results
=======

### Identification of differentially expressed miRNAs (DE-miRNAs) in BCa tissues

The obtained miRNA expression profiles (GSE76211) of BCa and normal bladder tissues were analyzed by the Affymetrix microRNA 4.0 Array, which contains 2,578 probes and can interrogate all mature miRNAs sequences in miRBase Release 20. The results revealed that 104 miRNAs were dysregulated in BCa group under the condition of 'P\<0.05 and fold change \>1.5', compared with normal bladder group. Among them, 102 miRNAs were downregulated and 2 were upregulated ([Fig. 1](#f1-mmr-16-06-8709){ref-type="fig"}). All of the dysregulated miRNA were listed in [Table II](#tII-mmr-16-06-8709){ref-type="table"}.

### Identification of putative target genes

The current study has identified 104 miRNAs that were significantly dysregulated in BCa tissues compared with normal bladder tissues. As miRNAs play their functional roles by regulating target genes expression at the posttranscriptional level, the authors predicted the target genes of dysregulated miRNAs using GCBI online tools, which were mainly based on the algorithms of miRanda and TargetScan. A total of 11,884 genes were predicted as putative target genes of dysregulated miRNAs.

### GO/pathway enrichment analysis of putative target genes of dysregulated miRNAs

To understand the role of miRNAs in cancer development, GO and pathway enrichment analysis were performed. The data in [Fig. 2A](#f2-mmr-16-06-8709){ref-type="fig"} indicated that the top 10 dysregulated GOs were 'transcription, DNA-dependent', 'signal transduction, positive regulation of transcription from RNA polymerase II promoter', 'regulation of transcription, DNA-dependent', 'axon guidance', 'positive regulation of transcription, DNA-dependent', 'apoptotic process', 'negative regulation of transcription from RNA polymerase II promoter', 'synaptic transmission' and 'negative regulation of transcription, DNA-dependent'. GO analysis obviously suggests that many dysregulated miRNAs may contribute to tumorigenesis of bladder through many important functions such as transcription regulation, signal transduction as well as apoptotic process. Combined with the KEGG database, the authors analyzed the pathways involving the putative target genes. As illustrated in [Fig. 2B](#f2-mmr-16-06-8709){ref-type="fig"}, the top ten dysregulated pathways were the mitogen-associated protein kinase (MAPK) signaling pathway, apoptosis, pathways in cancer, cell cycle, p53 signaling pathway, calcium signaling pathway, Wnt signaling pathway, adherens junction, focal adhesion and ErbB signaling pathway.

### Pathway network analysis

Then, pathway network (Path-net) analysis was performed to draw an interaction network covering 36 significantly changed pathways ([Fig. 3](#f3-mmr-16-06-8709){ref-type="fig"}). Among them, the MAPK signaling pathway (degree=44), apoptosis (degree=30), pathways in cancer (degree=29) and cell cycle (degree=24) showed the highest degree, suggesting that these four pathways might play a core role in regulation of bladder cancer development.

### miRNAs-gene-networks and miRNAs-GO-networks

Based on the significantly regulated GOs and pathways, the authors selected intersected genes and further constructed miRNAs-gene-networks and miRNAs-GO-networks to screen the key regulatory functions of the identified miRNAs and their target genes, respectively. As shown in [Figs. 4](#f4-mmr-16-06-8709){ref-type="fig"} and [5](#f5-mmr-16-06-8709){ref-type="fig"}, and [Table III](#tIII-mmr-16-06-8709){ref-type="table"}, the top rated nine miRNAs were hsa-miR-497-5p, hsa-miR-29a-3p, hsa-miR-124-3p, hsa-miR-4269, hsa-miR-145-5p, hsa-miR-204-5p, hsa-miR-4510, hsa-miR-6840-3p and hsa-miR-6722-3p. All of these miRNAs were downregulated in BCa tissues compared with normal bladder tissues. The microarray analysis demonstrated that the dysregulated miRNAs primarily play vital roles in various biological processes, including transcription regulation, apoptotic process, gene expression and signal transduction. Taken together, deregulation of certain miRNAs and several important pathways may be closely associated with human bladder cancer development.

### Validation of candidate miRNAs

To confirm that the top rated nine miRNAs identified were indeed dysregulated in BCa tissues, the authors used another miRNA expression profiling GSE40355 including 8 normal bladder tissues samples, 8 low grade BCa tissues samples and 8 high grade BCa tissue samples for validation. In the dataset of GSE40355, the expression values of candidate miRNAs between normal bladder tissue samples with high grade BCa tissue samples were extracted for t test, and P\<0.05 were considered statistically significant. In addition, 157 dysregulated miRNAs including 69 upregulated and 88 downregulated miRNAs were obtained by analysis of GSE40355. As presented in [Fig. 6](#f6-mmr-16-06-8709){ref-type="fig"} and [Table IV](#tIV-mmr-16-06-8709){ref-type="table"}, among the top rated nine miRNAs screened from our miRNA microarray, four miRNAs involving hsa-miR-497-5p, hsa-miR-29a-3p, hsa-miR-145-5p and hsa-miR-204-5p were also significantly altered in GSE40355.

Discussion
==========

In the current study, by comparing array-based miRNA expression profiling performed on three MIBC tissues and three normal bladder tissues, the integrated bioinformatic analysis from miRNA expression profiling identified that 104 miRNAs were differentially expressed (P\<0.05, fold change \>1.5), of which, 102 were downregulated and 2 were upregulated ([Fig. 1](#f1-mmr-16-06-8709){ref-type="fig"} and [Table II](#tII-mmr-16-06-8709){ref-type="table"}). Among the top 10 fold change miRNAs, many of them were closely linked to occurrence and development of bladder cancer and might play vital role as oncogenes and tumor suppressor genes, which has been published in several studies ([@b23-mmr-16-06-8709]--[@b27-mmr-16-06-8709]). Several studies have showed that miR-490-5p was significantly downregulated in BCa tissue samples compared with adjacent normal tissues ([@b28-mmr-16-06-8709]). Low expression of miR-139-3p, miR-133, miR-145 and miR-1 in MIBC tissue samples compared with normal tissues was also reported by studies and played a functional role in bladder cancer cell lines ([@b29-mmr-16-06-8709]--[@b32-mmr-16-06-8709]).

Then, 11,884 genes were predicted as putative target genes of dysregulated miRNAs using target prediction method in GCBI online tools. According to the GO analysis, the predicted target genes were mainly involved in 'transcription, DNA-dependent', signal transduction, positive regulation of transcription from RNA polymerase II promoter, 'regulation of transcription, DNA-dependent' and axon guidance ([Fig. 2A](#f2-mmr-16-06-8709){ref-type="fig"}). Interestingly, the authors noticed two pairs of opposite GOs (Negative regulation of transcription, DNA-dependent vs. Positive regulation of transcription, DNA-dependent and 'Negative regulation of transcription from RNA polymerase II promoter vs. Positive regulation of transcription from RNA polymerase II promoter'). miRNAs were involved in post-transcriptional regulation of gene expression ([@b33-mmr-16-06-8709]), which played a key role in various cellular processes including cellular differentiation, cell cycle progression and apoptosis. Among the predictive target genes of miRNAs, there may be lots of oncogenes and tumor suppressor genes. Oncogenes could promote BCa cell proliferation by positive regulation of transcription, in contrast, tumor suppressor genes could suppress BCa cell viability by negatively regulation of transcription. Therefore, it can be inferred that miRNA regulation disorders might account for these biological behaviors. As for biological pathways, the MAPK signaling pathway, apoptosis, pathways in cancer, cell cycle, p53 signaling pathway, calcium signaling pathway, Wnt signaling pathway, adherens junction, focal adhesion and Erbb signaling pathway were the top 10 enriched pathways of the predicted target genes ([Fig. 2B](#f2-mmr-16-06-8709){ref-type="fig"}). Many studies including our group ([@b17-mmr-16-06-8709]--[@b19-mmr-16-06-8709]) have ever reported that these pathways such as the MAPK signaling pathway, Wnt signaling pathway, p53 signaling pathway and Erbb signaling pathway play a functional role in human bladder cancer cells ([@b34-mmr-16-06-8709],[@b35-mmr-16-06-8709]). Besides, the Path-net analysis covering 36 significant pathways also showed that the MAPK signaling pathway, cell cycle, p53 signaling pathway, Wnt signaling pathway and calcium signaling pathway have a close correlation with bladder cancer, indicating that these pathways might play a key role in the development of human bladder cancer. In order to find out the key miRNAs, the authors conducted regulatory network analysis by overlapping significant miRNAs, pathways and GO analysis, revealing that the top nine miRNAs were hsa-miR-497-5p, hsa-miR-29a-3p, hsa-miR-124-3p, hsa-miR-4269, hsa-miR-145-5p, hsa-miR-204-5p, hsa-miR-4510, hsa-miR-6840-3p and hsa-miR-6722-3p. In order to validate that the nine candidate miRNAs identified were indeed dysregulated in BCa tissues, another miRNA microarray was performed by overlapping different expressed miRNAs and the top nine candidate miRNAs suggesting that four miRNAs involving hsa-miR-497-5p, hsa-miR-29a-3p, hsa-miR-145-5p and hsa-miR-204-5p were significantly altered. Moreover, as illustrated in [Figs. 4](#f4-mmr-16-06-8709){ref-type="fig"} and [5](#f5-mmr-16-06-8709){ref-type="fig"}, the top 10 target genes were TPM3, GXYLT1, SSH2, UBE2G1, CREB5, PARVA, TRAF3, IQSEC2, VANGL1 and IGF1R. Above all, these data showed that the regulatory network consisted of key miRNAs and genes may regulate biological process such as cell cycle, apoptosis and proliferation of human bladder cancer. Among the top ten target genes, tropomyosin 3 is a member of the tropomyosin family of actin-binding protein, which has been reported to relate to malignant transformation in BCa ([@b36-mmr-16-06-8709]). VANGL planar cell polarity 1 (VANGL1), as an oncogene, is associated with many cancers. Park *et al* ([@b37-mmr-16-06-8709]) revealed that miR-124 targeting VANGL could suppress colorectal cancer and Oh *et al* ([@b38-mmr-16-06-8709]) reported that VANGL1 has correlation with tumor progression in human colorectal cancer. Insulin-like growth factor 1 receptor (IGF1R), with tyrosine kinase activity, binds insulin-like growth factor with a high affinity, playing a critical role in tumorigenesis and chemosensitivity ([@b39-mmr-16-06-8709],[@b40-mmr-16-06-8709]). In the present study, IGF1R has high correlation with has-miR-378 family. Some studies indicated that miR-378 deficiency played a key role in the development of cardiac hypertrophy by targeting IGF1R through negatively regulated Ras signaling pathway ([@b41-mmr-16-06-8709]). Parvin alpha, a member of the parvin family of actin-binding proteins, playing a role in cell adhesion, motility and survival, is connected with different cancers, such as colorectal cancer and lung cancer ([@b42-mmr-16-06-8709]).

The four miRNAs screened out from the miRNA microarray and verified by another miRNA microarray indeed had a functional role in MIBC, which has been demonstrated by previous studies. Zhang *et al* ([@b43-mmr-16-06-8709]) reported that miR-497 was downregulated in BCa tissues compared with normal bladder tissues and may represent a novel prognostic biomarker for the early detection of metastasis of bladder cancer. Du *et al* ([@b44-mmr-16-06-8709]) also reported that miR-497 was decreased in plasma of bladder cancer patients compared with healthy patients and could be a promising novel circulating biomarkers in clinical detection of bladder cancer. Chiyomaru *et al* ([@b45-mmr-16-06-8709]) found that miR-145 was a tumor suppressor and inhibited cell viability by targeting FSCN1 in BCa cells. In addition, Avgeris *et al* ([@b46-mmr-16-06-8709]) suggested that miR-145 could act as a novel marker helpful for prediction of oncologic outcome for bladder cancer patients. However, there are no related reports about miR-29a-3p and miR-204-5p in BCa, therefore, the authors would like to investigate and confirm the two miRNAs using human BCa cell lines and mouse model in our next research article. However, predicting the miRNAs targets merely by bioinformatics analysis is not sufficient. Since the size of the MIBC samples used in the present study is small, these results may have many limitations. Thus, functional experiments should be performed strictly to verify the miRNAs and its targets in the further studies. As a result of that, the author group will select some of the significantly dysregulated miRNAs and perform verification experiments to confirm their targets and then figure out the functional role of miRNAs and the underlying mechanisms in MIBC.
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![Differential expression of miRNAs between normal bladder and MIBC tissues. Heatmap of 104 microRNAs differentially expressed between three normal bladder and three MIBC tissues. MIBC, muscle invasive bladder cancer.](MMR-16-06-8709-g06){#f1-mmr-16-06-8709}

![Significantly changed GO/pathways of predicted target genes of dysregulated miRNAs. (A) Significantly changed GOs of predicted target genes. The *y*-axis shows GO category and the *x*-axis shows -log10 (P-value). (B) Significantly changed pathways of predicted target genes. The γ-axis shows significantly changed pathways. GO, gene ontology.](MMR-16-06-8709-g07){#f2-mmr-16-06-8709}

![Pathway network (Path-net). Significantly changed pathways were connected in a Path-net to show the interaction network among these pathways. Each pathway in the network was measured by counting the upstream and downstream pathways. The blue circle represents pathways involving upregulated miRNAs, while the yellow circle represents pathways involving both upregulated and downregulated miRNAs. The size of the circle represents the degree value and the lines show the interaction between pathways. A higher degree of pathway indicates that it plays a more important role in the signaling network. miRNAs, microRNAs.](MMR-16-06-8709-g08){#f3-mmr-16-06-8709}

![miRNAs-gene-network. According to the interactions between miRNAs and the intersected target genes, miRNAs-gene-network was constructed to illustrate the key regulatory functions of the identified miRNAs and their target genes. The blue circles represent genes, while blue square nodes represent downregulated miRNAs. The size of the circle or square node represents the degree value. A higher degree of gene/miRNAs indicates that it plays a more important role in the signaling network. miRNA/miR, microRNA.](MMR-16-06-8709-g09){#f4-mmr-16-06-8709}

![miRNAs-GO-network. The miRNAs-GO-network was generated according to the relationship of significant biological functions and miRNAs. The yellow and blue circles represent GOs, red square nodes represent upregulated miRNAs, and blue square nodes represent downregulated miRNAs. The size of the circle or square node represents the degree value. A higher degree of GO/miRNAs indicates that it plays a more important role in the signaling network. GO, gene ontology; miRNA/miR, microRNA.](MMR-16-06-8709-g10){#f5-mmr-16-06-8709}

![Validation of candidate miRNAs. Among the top rated nine miRNAs screened from our miRNA microarray, four miRNAs involving (A) hsa-miR-145-5p, (B) hsa-miR-497-5p, (C) hsa-miR-29a-3p and (D) hsa-miR-204-5p were also significantly altered in GSE40355. miRNA, microRNA.](MMR-16-06-8709-g11){#f6-mmr-16-06-8709}

###### 

Information of the patients and donors.

  Characteristics          MIBC patients       Donors
  ------------------------ ------------------- ----------
  Number                   3                   3
  Age, years (mean ± SD)   62±1.581            37±2.327
  Gender                   Male                Male
  BCa stage                Stage II            --
  Surgical method          Radical resection   --

Stage II denotes that BCa enters the muscle layer of the bladder. SD, standard deviation; MIBC, muscle invasive bladder cancer; BCa, bladder cancer.

###### 

Differently expressed miRNAs in human MIBC tissues.

  MIBC tissues vs. normal bladder tissues. (P\<0.05, Fold-change \>1.5)                                   
  ----------------------------------------------------------------------- ------------- ---------- ------ -------
  hsa-miR-4786-5p                                                         −10.205618    0.00124    Down       1
  hsa-miR-490-3p                                                          −35.773813    0.001358   Down       2
  hsa-miR-3617-5p                                                         −42.647285    0.001476   Down       3
  hsa-miR-490-5p                                                          −75.331847    0.001594   Down       4
  hsa-miR-139-3p                                                          −32.552806    0.001712   Down       5
  hsa-miR-133b                                                            −121.234878   0.00183    Down       6
  hsa-miR-145-3p                                                          −9.840205     0.001948   Down       7
  hsa-miR-29b-1-5p                                                        −10.581222    0.002066   Down       8
  hsa-miR-155-5p                                                          8.720112      0.002184   UP         9
  hsa-miR-1                                                               −40.712728    0.002302   Down     10
  hsa-miR-548q                                                            −5.779384     0.00242    Down     11
  hsa-miR-133a-5p                                                         −17.075477    0.002774   Down     12
  hsa-miR-146b-5p                                                         4.140864      0.002893   UP       13
  hsa-miR-28-3p                                                           −3.834537     0.003129   Down     14
  hsa-miR-30c-2-3p                                                        −11.293849    0.003247   Down     15
  hsa-miR-143-5p                                                          −15.820855    0.003365   Down     16
  hsa-miR-6511b-3p                                                        −6.432579     0.003601   Down     17
  hsa-miR-320e                                                            −3.630028     0.003719   Down     18
  hsa-miR-99a-3p                                                          −2.325859     0.003837   Down     19
  hsa-miR-30a-3p                                                          −18.900354    0.003955   Down     20
  hsa-miR-133a-3p                                                         −63.82892     0.004073   Down     21
  hsa-miR-4510                                                            −2.805811     0.004545   Down     22
  hsa-miR-139-5p                                                          −12.808018    0.004782   Down     23
  hsa-miR-4324                                                            −19.035251    0.005136   Down     24
  hsa-miR-145-5p                                                          −3.499059     0.005372   Down     25
  hsa-miR-125b-1-3p                                                       −13.117689    0.005608   Down     26
  hsa-miR-143-3p                                                          −3.894089     0.005962   Down     27
  hsa-miR-193a-5p                                                         −4.050292     0.006198   Down     28
  hsa-miR-5684                                                            −4.681531     0.007261   Down     29
  hsa-miR-328-3p                                                          −8.31845      0.007379   Down     30
  hsa-miR-4429                                                            −2.76178      0.007497   Down     31
  hsa-miR-1287-5p                                                         −7.357196     0.007615   Down     32
  hsa-miR-3605-5p                                                         −2.739437     0.007969   Down     33
  hsa-miR-338-5p                                                          −4.852428     0.008323   Down     34
  hsa-miR-193a-3p                                                         −9.317892     0.00856    Down     35
  hsa-miR-4257                                                            −3.696435     0.008796   Down     36
  hsa-miR-6507-5p                                                         −6.813232     0.010331   Down     37
  hsa-miR-6722-3p                                                         −2.904131     0.011275   Down     38
  hsa-miR-497-5p                                                          −3.273151     0.011865   Down     39
  hsa-miR-125b-2-3p                                                       −7.613095     0.012574   Down     40
  hsa-miR-29b-2-5p                                                        −2.995467     0.013046   Down     41
  hsa-miR-6511a-3p                                                        −8.396761     0.013282   Down     42
  hsa-miR-628-3p                                                          −4.613832     0.013636   Down     43
  hsa-miR-378b                                                            −6.024561     0.014581   Down     44
  hsa-miR-664a-5p                                                         −6.119249     0.014699   Down     45
  hsa-miR-204-5p                                                          −6.006885     0.015525   Down     46
  hsa-miR-7641                                                            −4.116459     0.015762   Down     47
  hsa-miR-320d                                                            −2.149376     0.016706   Down     48
  hsa-miR-3656                                                            −2.093619     0.017414   Down     49
  hsa-miR-1273g-3p                                                        −2.156204     0.017769   Down     50
  hsa-miR-378g                                                            −7.277976     0.018359   Down     51
  hsa-miR-1225-5p                                                         −2.552195     0.019067   Down     52
  hsa-miR-3156-5p                                                         −6.520017     0.019421   Down     53
  hsa-miR-383-5p                                                          −3.70084      0.019658   Down     54
  hsa-miR-3064-3p                                                         −2.07381      0.020012   Down     55
  hsa-miR-378d                                                            −5.5391       0.02013    Down     56
  hsa-miR-23b-5p                                                          −9.113128     0.020366   Down     57
  hsa-miR-3195                                                            −10.384316    0.020484   Down     58
  hsa-miR-100-5p                                                          −3.57042      0.020956   Down     59
  hsa-miR-378e                                                            −14.003579    0.021547   Down     60
  hsa-miR-4649-5p                                                         −2.337674     0.022019   Down     61
  hsa-miR-3622b-5p                                                        −3.04368      0.022373   Down     62
  hsa-miR-6840-3p                                                         −6.817266     0.024616   Down     63
  hsa-miR-4322                                                            −6.233632     0.024852   Down     64
  hsa-miR-574-5p                                                          −5.490031     0.025207   Down     65
  hsa-miR-4770                                                            −4.247774     0.025561   Down     66
  hsa-miR-513a-5p                                                         −3.907964     0.025679   Down     67
  hsa-miR-124-3p                                                          −1.707013     0.025797   Down     68
  hsa-miR-6819-5p                                                         −2.385821     0.026151   Down     69
  hsa-miR-339-3p                                                          −5.134485     0.027332   Down     70
  hsa-miR-26b-3p                                                          −3.129563     0.02745    Down     71
  hsa-miR-29c-5p                                                          −7.931159     0.027922   Down     72
  hsa-miR-29a-3p                                                          −2.906434     0.02804    Down     73
  hsa-miR-1227-5p                                                         −2.287321     0.028276   Down     74
  hsa-miR-4327                                                            −2.710984     0.028512   Down     75
  hsa-miR-99a-5p                                                          −4.947917     0.02863    Down     76
  hsa-miR-1296-5p                                                         −9.401257     0.029103   Down     77
  hsa-miR-378i                                                            −4.649838     0.030283   Down     78
  hsa-miR-6889-5p                                                         −4.810854     0.030401   Down     79
  hsa-miR-186-5p                                                          −3.276383     0.031464   Down     80
  hsa-miR-6824-5p                                                         −8.197661     0.031936   Down     81
  hsa-miR-195-3p                                                          −4.796311     0.034416   Down     82
  hsa-miR-3622a-5p                                                        −4.145204     0.034888   Down     83
  hsa-miR-5572                                                            −6.053895     0.03536    Down     84
  hsa-miR-6776-5p                                                         −3.050977     0.035832   Down     85
  hsa-miR-6790-5p                                                         −2.868339     0.036895   Down     86
  hsa-miR-6740-5p                                                         −2.087867     0.037721   Down     87
  hsa-miR-4269                                                            −8.226931     0.038312   Down     88
  hsa-miR-125b-5p                                                         −2.694152     0.039138   Down     89
  hsa-miR-3188                                                            −8.008159     0.039256   Down     90
  hsa-miR-6787-5p                                                         −2.714687     0.03961    Down     91
  hsa-miR-99b-5p                                                          −1.811603     0.039847   Down     92
  hsa-miR-30a-5p                                                          −3.787576     0.040673   Down     93
  hsa-miR-6765-5p                                                         −2.365181     0.041027   Down     94
  hsa-miR-1909-3p                                                         −7.648533     0.041972   Down     95
  hsa-miR-4507                                                            −2.786848     0.042326   Down     96
  hsa-miR-28-5p                                                           −2.529154     0.042916   Down     97
  hsa-miR-6892-5p                                                         −2.081233     0.046458   Down     98
  hsa-miR-4433b-3p                                                        −1.923165     0.046694   Down     99
  hsa-miR-6737-5p                                                         −3.166103     0.04693    Down   100
  hsa-miR-324-3p                                                          −3.939764     0.048465   Down   101
  hsa-miR-211-3p                                                          −3.140159     0.048819   Down   102
  hsa-miR-6798-5p                                                         −2.080154     0.049174   Down   103
  hsa-miR-4299                                                            −4.93377      0.049882   Down   104

Changes of miRNA expression in MIBC compared with normal bladder.

Ranking method is in descending order according to statistical significance (P-value) between the two groups. miRNA/miR, microRNA; MIBC, muscle invasive bladder cancer; Up, upregulated in MIBC; Down, downregulated in MIBC.

###### 

The top 10 miRNAs with high degrees of miRNAs-gene-networks and miRNAs-GO-networks.

  Rank   miRNAs            miRNA-gene-networks degree^[a](#tfn4-mmr-16-06-8709){ref-type="table-fn"}^   Feature^[b](#tfn5-mmr-16-06-8709){ref-type="table-fn"}^   miRNAs            miRNA-GO-networks degree^[a](#tfn4-mmr-16-06-8709){ref-type="table-fn"}^   Feature^[b](#tfn5-mmr-16-06-8709){ref-type="table-fn"}^
  ------ ----------------- ---------------------------------------------------------------------------- --------------------------------------------------------- ----------------- -------------------------------------------------------------------------- ---------------------------------------------------------
    1    hsa-miR-497-5p    123                                                                          Down                                                      hsa-miR-497-5p    637                                                                        Down
    2    hsa-miR-29a-3p      88                                                                         Down                                                      hsa-miR-29a-3p    518                                                                        Down
    3    hsa-miR-124-3p      84                                                                         Down                                                      hsa-miR-124-3p    516                                                                        Down
    4    hsa-miR-4269        64                                                                         Down                                                      hsa-miR-204-5p    494                                                                        Down
    5    hsa-miR-145-5p      63                                                                         Down                                                      hsa-miR-4269      458                                                                        Down
    6    hsa-miR-204-5p      62                                                                         Down                                                      hsa-miR-145-5p    430                                                                        Down
    7    hsa-miR-4510        61                                                                         Down                                                      hsa-miR-6840-3p   406                                                                        Down
    8    hsa-miR-125b-5p     57                                                                         Down                                                      hsa-miR-4510      404                                                                        Down
    9    hsa-miR-6840-3p     50                                                                         Down                                                      hsa-miR-6722-3p   387                                                                        Down
  10     hsa-miR-6722-3p     47                                                                         Down                                                      hsa-miR-1         383                                                                        Down

Changes of miRNA expression in MIBC compared with normal bladder.

Total number of connections around the miRNA. miRNA/miR, microRNA; GO, gene ontology; Down, downregulated in muscle invasive bladder cancer.

###### 

The alteration of top rated nine miRNAs in GSE76211 and GSE40355.

                    GSE76211   GSE40355                                   
  ----------------- ---------- ---------- ------ --------- -------------- ------
  hsa-miR-497-5p    −3.27      0.011865   Down   −7.94     5.94×10^−5^    Down
  hsa-miR-29a-3p    −2.90      0.02804    Down   −3.61     0.0003         Down
  hsa-miR-124-3p    −1.70      0.025797   Down   --        --             Down
  hsa-miR-4269      −8.22      0.038312   Down   --        --             Down
  hsa-miR-145-5p    −3.49      0.005372   Down   −52.69    4.39×10^−8^    Down
  hsa-miR-204-5p    −6.00      0.015525   Down   −463.33   1.89×10^−10^   Down
  hsa-miR-4510      −2.80      0.004545   Down   --        --             Down
  hsa-miR-6840-3p   −6.81      0.024616   Down   --        --             Down
  hsa-miR-6722-3p   −2.90      0.011275   Down   --        --             Down

Changes of miRNA expression in MIBC compared with normal bladder. miRNA/miR, microRNA; MIBC, muscle invasive bladder cancer; Down, downregulated in MIBC.

[^1]: Contributed equally
